4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-335538
Chief Executive Officer gave up 306,846 shares (to pay taxes)
- Chief Executive Officer acquired 550,000 shares (option exercise)
- Chief Executive Officer gave 243,154 shares (gift)
- Chief Executive Officer acquired 243,154 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2025-12-24 | Option exercise | +550,000 | $3.88 | $2,134,000 | 550,000 | D: show line 1 in the form |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-12-24 | Shares withheld for taxes | −306,846 | $83.59 | $25,649,257 | 243,154 | D: show line 2 in the form |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-12-24 | Gift | −243,154 | 0 | D: show line 3 in the form | ||
| BELANOFF JOSEPH K Chief Executive Officer | 2025-12-24 | Other acquisition | +243,154 | 2,944,524 | I: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2025-12-24 | Option exercise · Stock option (right to buy) | −550,000 | 0 | D: show line 5 in the form |
Loading xslF345X05/ownership.xml…